fluorodeoxyglucose f18 has been researched along with Atheroma in 152 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 121 (79.61) | 24.3611 |
2020's | 31 (20.39) | 2.80 |
Authors | Studies |
---|---|
Dey, AK; Manyak, GA; Mehta, NN; Parel, PM; Patel, NH; Playford, MP; Sorokin, AV; Svirydava, M; Teague, HL; Teklu, M; Zhou, W | 1 |
Abdelwahed, YS; Bigalke, B; Botnar, RM; Brenner, W; Engel, LC; Fröhlich, G; Furth, C; Haghikia, A; Hamm, B; Landmesser, U; Leistner, DM; Makowski, MR; Morguet, A; Noutsias, M; Schulze, D; Schuster, A; Skurk, C; Wurster, TH | 1 |
Aguilera-Simón, A; Benitez, S; Camacho, M; Camps-Renom, P; Fernández-León, A; Jiménez-Altayó, F; Jiménez-Xarrié, E; Marín, R; Martí-Fàbregas, J; Puig, N; Sánchez-Quesada, JL | 1 |
Kwiecinski, J | 1 |
Alavi, A; Høilund-Carlsen, PF; Revheim, ME; Werner, TJ | 1 |
Andrés, V; Bueno, H; Devesa, A; España, S; Fernández-Friera, L; Fernández-Ortiz, A; Fuster, JJ; Fuster, V; García-Lunar, I; Ibanez, B; Lobo-González, M; Martínez-Milla, J; Mastrangelo, A; Mendiguren, JM; Oliva, B; Rossello, X; Sanchez-Gonzalez, J; Sancho, D; Sanz, J | 1 |
Brits, B; Davis, C; Hlongwa, KN; Lawal, IO; Mahapane, J; Maserumule, LC; Mokoala, KMG; Ndlovu, H; Popoola, GO; Sathekge, MM | 1 |
Kadoglou, NP; Khattab, E; Lambadiari, V; Patsourakos, N; Velidakis, N | 1 |
Agard, C; Bénichou, A; Coudol, S; Espitia, O; Guédon, AF; Jamet, B; Karakachoff, M; Kraeber-Bodéré, F; Schanus, J; Serfaty, JM | 1 |
Al-Enezi, MS; Bentourkia, M; Berrahmoune, N; Croteau, É; Douhi, A; Fulop, T; Khalil, A; Nguyen, M; Turcotte, E | 1 |
Aguilera-Simón, A; Benitez, S; Benitez-Amaro, A; Camps-Renom, P; Fernández-Leon, A; Garcia, E; Jiménez-Xarrié, E; Llorente-Cortés, V; Martí-Fàbregas, J; Puig, N; Sanchez-Quesada, JL; Solé, A; Vilades, D | 1 |
Buck, AK; Derlin, T; Hartrampf, PE; Higuchi, T; Kosmala, A; Lindner, T; Michalski, K; Schirbel, A; Serfling, SE; Weich, A; Werner, RA | 1 |
Barry, M; Camps-Renom, P; Cassidy, T; Cronin, S; Dolan, E; Fernández-León, A; Foley, S; Giannotti, N; Gorey, S; Harbison, J; Kelly, PJ; Marnane, M; Martí-Fabregas, J; McCabe, JJ; McNulty, JP; O'Connell, M; Williams, DJ | 1 |
Bhakta, S; Evans, NR; Gorey, S; Kelly, PJ; McCabe, JJ; Rudd, JHF | 1 |
Liu, L; Ma, J; Wang, J; Wang, M; Zhang, C; Zhang, J | 1 |
Ahlman, MA; Blocki, F; Bonelli, F; Chen, MY; Dey, AK; Elnabawi, YA; Harrington, CL; Joshi, AA; Mehta, NN; Playford, MP; Rivers, JP; Rodante, JA; Teague, HL; Zierold, C | 1 |
Bhatt, DL; Di Carli, M; Libby, P | 1 |
Chowdhury, MM; Evans, NR; Le, EPV; Rudd, JHF; Sriranjan, RS; Tarkin, JM | 1 |
Jiang, Y; Li, L; Li, M; Wu, W; Zhang, P | 1 |
Anagnostopoulos, CD; Georgakopoulos, AT; Kafouris, PP; Koutagiar, IP; Spyrou, GM; Visvikis, D | 1 |
Motwani, M | 1 |
Ju, S; Li, Y; Liang, Y; Xu, Y; Yan, J; Yang, P; Zhang, N; Zhu, X; Zhu, Y | 1 |
Russell, D; Scott, H; Skagen, K; Skjelland, M; Zamani, M | 1 |
Kim, EJ; Kim, S; Lee, YJ; Pahk, K; Seo, HS | 1 |
Gomez, MF; Hellberg, S; Huusko, J; Knuuti, J; Liljenbäck, H; Nuutila, P; Roivainen, A; Saraste, A; Silvola, JMU; Söderström, M; Ståhle, M; Virta, J; Ylä-Herttuala, S | 1 |
Al-Mallah, MH; Hyafil, F; Santulli, G | 1 |
Choi, CU; Eo, JS; Kang, DO; Kim, CK; Kim, EJ; Kim, JW; Na, JO; Nam, HS; Park, CG; Park, EJ; Park, SY; Park, YH; Rha, SW; Seo, HS; Song, JW; Yoo, H | 1 |
Amarenco, P; Cabrejo, L; Guidoux, C; Hobeanu, C; Hyafil, F; Klein, I; Lavallée, P; Lesèche, G; Meseguer, E; Mikail, N | 1 |
Cortes-Canteli, M; Falcon, C; Fernandez-Friera, L; Fernandez-Ortiz, A; Fuster, V; Garcia-Ruiz, JM; Gispert, JD; Ibanez, B; Mendiguren, J; Molinuevo, JL; Oliva, B; Salvadó, G; Sanchez-Gonzalez, J; Sanz, J; Toribio-Fernandez, R; Tristão-Pereira, C | 1 |
Hoogeveen, RM; Kaiser, Y; Kroon, J; Moens, SJB; Stroes, ESG; Verberne, HJ; Verweij, SL; Vogt, L | 1 |
Mannes, PZ; Tavakoli, S | 1 |
Ahlström, H; de Muinck, E; Dyverfeldt, P; Good, E; Lubberink, M; Ochoa-Figueroa, M; Ressner, M; Warntjes, M; Ziegler, M | 1 |
Dilsizian, V; Jadvar, H | 1 |
Abrunhosa, A; Castelo-Branco, M; Chichorro, N; Donato, P; Ferreira, MJ; Gomes, A; Gonçalves, L; Oliveira-Santos, M; Pedroso de Lima, J; Pego, M; Silva, R | 1 |
Beanlands, RSB; deKemp, RA; Wells, RG | 1 |
Narula, J; Strauss, HW | 2 |
Aigbirhio, FI; Davenport, AP; Figg, NL; Fryer, TD; Joshi, FR; Kirkpatrick, PJ; Manavaki, R; Rudd, JH; Sluimer, JC; Warburton, EA | 1 |
Hellberg, S; Jauhiainen, M; Knuuti, J; Liljenbäck, H; Metso, J; Nuutila, P; Roivainen, A; Saraste, A; Saukko, P; Savisto, N; Silvola, JMU; Sippola, S; Ståhle, M; Virta, J; Ylä-Herttuala, S | 1 |
Bacchi Reggiani, ML; Bonfiglioli, R; Fanti, S; Ghetti, G; Lima, GM; Marco, V; Nanni, C; Prati, F; Rapezzi, C; Saia, F; Taglieri, N | 1 |
Asmis, R; Downs, K; Goins, B; Jerabek, PA; Lai, Y; Nguyen, HN; Sadeghi, MM; Short, JD; Tavakoli, S; Toczek, J | 1 |
Boellaard, R; Comans, EFI; Heymans, MW; Lensen, KDF; Nurmohamed, MT; Smulders, YM; van der Laken, CJ; van Sijl, AM; Voskuyl, AE | 1 |
Cook, R; Dey, AK; Eder, L; Gladman, DD; Joshi, AA; Mehta, NN; Siegel, EL | 1 |
Bekkering, S; Bernelot Moens, SJ; Duivenvoorden, R; Nahrendorf, M; Nurmohamed, NS; Stiekema, LCA; Stroes, ESG; van der Valk, FM; Verberne, HJ; Versloot, M; Verweij, SL | 1 |
Celeng, C; de Jong, P; de Keizer, B; Leiner, T; Merkely, B; Takx, RAP | 1 |
Andrews, JPM; Dweck, MR; Fayad, ZA | 1 |
Hyafil, F; Vigne, J | 2 |
Chowdhury, MM; Coughlin, PA; Evans, NR; Hayes, PD; Le, E; Rudd, JHF; Tarkin, JM; Warburton, EA | 1 |
Chang, K; Chu, EH; Han, EJ; Hwang, BH; Kim, CJ; Kim, JJ; Kim, SH; O, JH; Seung, KB | 1 |
Akioka, N; Kashiwazaki, D; Kuroda, S; Kuwayama, N; Noguchi, K; Yamamoto, S | 1 |
Pelletier-Galarneau, M; Ruddy, TD | 1 |
Bucerius, J; Dijkgraaf, I; Mottaghy, FM; Schurgers, LJ | 1 |
Kim, JM; Kwon, OS; Lee, ES; Park, KY; Seok, JW | 1 |
Abdo, RA; Al-Enezi, MS; Bentourkia, M; Fulop, T; Khalil, A; Mokeddem, MY; Slimani, FAA; Turcotte, E | 1 |
Alavi, A; Gerke, O; Høilund-Carlsen, PF; Moghbel, MC | 1 |
Rischpler, C; Woodard, PK | 1 |
Albaghdadi, MS; Berrett, TB; Buscombe, JR; Chowdhury, MM; Coughlin, PA; Dweck, MR; Evans, NR; Hayes, PD; Joshi, FR; Le, EPV; Newby, DE; Rudd, JHF; Sadat, U; Tarkin, JM; Warburton, EA | 1 |
Banzo, I; Carril, JM; Jiménez-Bonilla, JF; Martínez-Rodríguez, I; Quirce, R; Rebollo, M; Rubio-Vassallo, A | 1 |
Ballet, S; Bini, J; Corot, C; Dickson, SD; Fayad, ZA; Izquierdo-Garcia, D; Klink, A; Lancelot, E; Mateo de Castro, J; Millon, A; Robert, P | 1 |
Chen, W; Dilsizian, V | 1 |
Feng, TT; Li, DP; Li, LQ; Liu, Y; Zhang, MD; Zhao, QM; Zhao, X; Zhao, XC; Zhuang, XC | 2 |
Hirata, K; Houkin, K; Kuroda, S; Magota, K; Nakayama, N; Saito, H; Shiga, T; Tamaki, N; Terae, S; Yoshida, D | 1 |
Beanlands, RS; Chow, BJ; DaSilva, J; deKemp, RA; Dwivedi, G; Garrard, L; Ghosh, N; Guo, A; Liu, Y; Ruddy, TD | 1 |
Abdelbaky, A; Alon, A; Beals, CR; Dansky, H; Farkouh, ME; Fayad, ZA; Klimas, MT; Mogg, R; Nunes, IO; Rudd, JH; Shankar, SS; Subramanian, SS; Tawakol, A | 1 |
Akers, SR; Alavi, A; Blomberg, BA; Cheng, G; Del Bello, C; Lim, E; Mehta, NN; Saboury, B; Torigian, DA; Werner, TJ | 1 |
Asada, Y; Iwakiri, T; Kawai, K; Koshimoto, C; Kuge, Y; Matsuura, Y; Ohe, K; Okuyama, N; Sugita, C; Tamaki, N; Yamashita, A; Zhao, S; Zhao, Y | 1 |
Daemen, MJ; Marsch, E; Sluimer, JC | 1 |
Chen, HJ; Cheng, LQ; Gai, JJ; Li, J; Liu, HB; Liu, JJ; Wang, Y; Xie, LX; Yin, DY; Zhang, XW; Zhao, XH | 1 |
Backes, WH; Bucerius, J; Daemen, MJ; Hermeling, E; Kooi, ME; Kwee, RM; Mess, WH; Truijman, MT; van Hoof, RH; van Oostenbrugge, RJ; Wildberger, JE | 1 |
Duivenvoorden, R; Farkouh, ME; Fayad, ZA; Fuster, V; Kallend, D; Mani, V; Rudd, JHF; Suchankova, G; Tawakol, A; Woodward, M | 1 |
Behan, MW; Calvert, PA; Craighead, FH; Cruden, NL; Dweck, MR; Flapan, AD; Fletcher, AM; Fox, KA; Joshi, NV; Mills, NL; Newby, DE; Rudd, JH; Salter, D; Shah, AS; Uren, NG; van Beek, EJ; Vesey, AT; Wallace, W; Williams, MC; Yeoh, SE | 1 |
Haraszti, RA; Thomas, GS | 1 |
Horiguchi, T; Ikeda, S; Ishino, S; Magata, Y; Mori, I; Nishimura, S; Ogawa, M; Oikawa, T; Sugita, T | 1 |
Gersak, B; Jezovnik, MK; Lezaic, L; Poredos, P; Zidar, N | 1 |
Abt, M; Bucerius, J; Fayad, ZA; Kallend, D; Mani, V; Rudd, JH; Samber, D; Tawakol, A; Woodward, M | 1 |
Brittenden, J; McKiddie, F; Murray, A; Ramalingam, SL; Shaikh, S; Welch, A; Wilson, HM | 1 |
Ametamey, SM; Beck, K; Betzel, T; Fischer, CR; Kaufmann, PA; Krämer, SD; Müller, A; Müller, C; Rancic, Z; Schibli, R | 1 |
Hermann, S; Jacobs, AH; Kloth, C; Kuhlmann, MT; Schäfers, MA; Schober, O; Wenning, C | 1 |
Akijian, L; Barry, M; Chróinín, DN; Crowe, M; Dolan, E; Fallon, E; Horgan, G; Kavanagh, E; Kelly, PJ; Marnane, M; McDonnell, C; Merwick, A; Murphy, S; Noone, I; O'Connell, M; O'Donohoe, M; O'Malley, K; O'Rourke, K | 1 |
Chen, H; Guan, Z; Han, X; Liang, C; Liu, H; Sun, J; Wang, J; Wei, L; Xie, L; Xue, H; Yu, S; Yuan, C; Zhao, X | 1 |
Bird, J; Clark, J; Cuhlmann, S; Davenport, AP; Evans, PC; Gsell, W; Habib, J; Haskard, D; Jones, H; Khalil, M; Krams, R; Kwak, BR; Meens, MJ; Tremoleda, JL; Turkheimer, F; Van der Heiden, K | 1 |
Caobelli, F | 1 |
Cho, YS; Choi, JY; Hong, SP; Hyun, SH; Kim, BT; Lee, KH; Moon, SH; Noh, TS | 1 |
Joshi, FR; Rudd, JH; Tarkin, JM | 1 |
Dweck, MR; Newby, DE; Toor, IS | 1 |
Baccega, M; Conrotto, F; D'Ascenzo, F; De Berardinis, A; Fava, A; Grasso, C; Lesca, A; Marra, S; Sbarra, P | 1 |
Bol, A; Demeure, F; Gerber, B; Hanin, FX; Jamar, F; Pasquet, A; Pouleur, AC; Vancraeynest, D; Vanoverschelde, JL; Vincent, MF | 1 |
Avanesov, M; Derlin, T; Karul, M | 1 |
Alberini, JL; Bélissant, O; Champion, L | 1 |
Belkin, M; Di Carli, MF; Folco, EJ; Jerosch-Herold, M; Kwong, RY; Libby, P; Murthy, VL; Nahrendorf, M; Ozaki, CK; Sukhova, GK; Taqueti, VR; Weissleder, R | 1 |
Carpenter, C; Kosuge, H; McConnell, MV; Pratx, G; Xing, L; Zaman, RT | 1 |
Emami, H; Tawakol, A | 1 |
Joshi, FR; Rajani, NK; Rudd, JH; Tarkin, JM | 1 |
Burg, S; Buvat, I; Huet, P; Hyafil, F; Le Guludec, D | 1 |
Lv, SZ; Wang, ZM; Yan, YF; Zhang, MD; Zhang, YH; Zhao, QM; Zhao, XC | 1 |
Gillard, JH; Graves, MJ; Lin, JM; Makris, GC; Patterson, AJ; Teng, Z; Young, V | 1 |
Paliwal, PR; Sharma, VK; Sinha, AK | 1 |
Carpenter, C; Kosuge, H; McConnell, MV; Sun, C; Xing, L; Zaman, RT | 1 |
Bartenstein, P; Habs, M; Hacker, M; Hetterich, H; Reiser, MF; Rominger, A; Saam, T; Volpers, S; Walter, L | 1 |
Abdelbaky, A; Ballantyne, CM; Du, S; Ehlgen, A; Emami, H; Farkouh, ME; Farmer, M; Fayad, ZA; Hayes, W; Kim, J; Langenickel, TH; Li, L; Mohler, ER; Roth, E; Subramanian, S; Tawakol, A; Velasquez, L; Vucic, E | 1 |
Daemen, MJ; Lambin, P; Nederveen, AJ; Sluimer, JC; Stroes, ES; van der Valk, FM; Verberne, HJ; Vöö, SA; Windhorst, AD | 1 |
Buscombe, JR | 1 |
Banzo, I; Carril, JM; Ibáñez-Bravo, S; Jiménez-Alonso, M; Jiménez-Bonilla, J; López-Defilló, J; Martínez-Amador, N; Martínez-Rodríguez, I; Quirce, R; Revilla, MA | 1 |
Alessio, AM; Caldwell, JH; Ferguson, MS; Hatsukami, TS; Hippe, DS; Kerwin, WS; Kohler, TR; Liu, J; Martinez-Malo, V; Miyaoka, RS; Pimentel, K; Yuan, C | 1 |
Alam, SR; Carruthers, K; Dweck, MR; Fletcher, AM; Fox, KA; Hoo, TY; Jenkins, WS; Joshi, NV; Langlands, SP; Melville, AJ; Mills, NL; Newby, DE; Rudd, JH; Shah, AS; Sills, A; Toor, I; Uren, NG; van Beek, EJ; Vesey, AT | 1 |
Belanger, AP; Binderup, T; Calcagno, C; Courties, G; Di Carli, MF; Dubey, S; Fayad, ZA; Ishino, S; Iwamoto, Y; Johnbeck, CB; Keliher, EJ; Kjaer, A; Knigge, U; Libby, P; Mani, V; Mulder, WJ; Nahrendorf, M; Pérez-Medina, C; Swirski, FK; Tang, J; Tawakol, A; Weissleder, R; Wojtkiewicz, GR; Ye, YX | 1 |
Bayer-Karpinska, A; Boeckh-Behrens, T; Dichgans, M; Hacker, M; Höhn, S; Hyafil, F; Nekolla, SG; Obenhuber, T; Poppert, H; Rominger, A; Saam, T; Schindler, A; Schwaiger, M; Sepp, D | 1 |
AlJaroudi, WA; Hage, FG | 1 |
Bala, G; Blykers, A; Broisat, A; Caveliers, V; Cosyns, B; Descamps, B; Devoogdt, N; Droogmans, S; Fagret, D; Ghezzi, C; Hernot, S; Lahoutte, T; Van Camp, G; Vanhove, C; Xavier, C | 1 |
Beitzke, D; Beyer, T; Hacker, M; Hartenbach, M; Haug, A; Heber, D; Kreissl, M; Li, X; Loewe, C; Mayerhoefer, ME; Mitthauser, M; Rasul, S; Rausch, I; Wadsak, W; Zhang, X | 1 |
Balatsos, N; Castejón, B; Cuadrado, I; Herruzo, I; Martin, AM; Saura, M; Zamorano, JL; Zaragoza, C | 1 |
Berent, R; Brammen, L; Sinzinger, H; Steiner, S | 1 |
Ishihara, K; Kiriyama, T; Kobayashi, Y; Kumita, SI; Onoguchi, M; Sakurai, M; Shibutani, T; Suda, M | 1 |
Jezovnik, MK; Lezaic, L; Mijovski, MB; Poredos, P; Spirkoska, A | 1 |
Abe, T; Bekki, M; Fujimoto, K; Fukumoto, Y; Honda, A; Igata, S; Koiwaya, H; Kurata, S; Nakamura, T; Ohtsuka, M; Shibata, Y; Sugiyama, Y; Tahara, A; Tahara, N; Ueno, T | 1 |
Chowdhury, MM; Evans, NR; Rudd, JH; Sriranjan, RS; Tarkin, JM | 1 |
Ahn, JM; Chang, M; Kang, SJ; Kim, YH; Lee, CW; Lee, HS; Lee, SW; Moon, DH; Oh, M; Park, DW; Park, SJ; Park, SW | 1 |
Dregely, I; Dzijan-Horn, M; Ganter, C; Ibrahim, T; Joner, M; Koppara, T; Kuhs, K; Langwieser, N; Laugwitz, KL; Nährig, J; Nekolla, SG; Schwaiger, M | 1 |
Aggeli, C; Agrogiannis, G; Anagnostopoulos, CD; Athanasiadis, E; Benetos, G; Bessias, N; Cokkinos, D; Filis, K; Georgakopoulos, A; Kafouris, P; Klonaris, C; Koutagiar, I; Patelis, N; Patsouris, E; Pianou, N; Siores, E; Spyrou, G; Tousoulis, D; Toutouzas, K; Trachanellis, S; Tsiamis, E | 1 |
Abela, GS; Berger, K; Durga, S; Janoudi, A; Pervaiz, MH | 1 |
Fayad, ZA; Osborne, MT; Tawakol, A | 1 |
Akram, K; Sheikine, Y | 1 |
Gonen, M; Meirelles, GS; Strauss, HW | 1 |
Blankenberg, FG; Kuge, Y; Strauss, WH; Tamaki, N; Zhao, S; Zhao, Y | 1 |
Hansen, T; Johansson, L; Sörensen, J; Wanhainen, A | 1 |
Choudhury, RP; Fayad, ZA; Lindsay, AC; Owen, DR | 1 |
Brady, TJ; Fifer, KM; Figueroa, AL; Hoffmann, U; Qadir, S; Subramanian, S; Tawakol, A; Truong, QA; Vijayakumar, J | 1 |
Feng, TT; Li, DP; Li, LQ; Liu, Y; Su, G; Xu, ZM; Zhang, XX; Zhao, QM; Zhao, X | 1 |
Ruddy, TD; Small, GR | 1 |
Apostolova, I; Buchert, R; Derlin, T; Habermann, CR; Hahne, JD; Klutmann, S; Mester, J | 1 |
Beller, GA | 1 |
Apostolova, I; Derlin, T; Habermann, CR; Klutmann, S; Mester, J; Papp, L; Tóth, Z; Wisotzki, C | 1 |
Graebe, M; Hag, AM; Hoejgaard, L; Kjaer, A; Pedersen, SF; Sillesen, H | 1 |
Artigas, C; Carrió, I; Deportos, J; Fernández, Y; Flotats, A; Gaeta, C; Geraldo, L; Pavía, J | 1 |
Abela, GS; Abela, OG; Aziz, K; Berger, K; Janoudi, A; Patel, R; Rubinstein, J; Tamhane, U; Vedre, A | 1 |
Bansilal, S; Burgess, T; Farkouh, ME; Fayad, ZA; Fuster, V; Kallend, D; Mani, V; Pozza, J; Rudd, JH; Tawakol, A; Woodward, M | 1 |
Agu, O; Brookes, J; Ell, PJ; Endozo, R; Goh, VJ; Groves, AM; Harvey, R; Kotze, CW; Menezes, LJ; Richards, T; Rodriguez-Justo, M; Yusuf, SW | 1 |
Brady, TJ; Cury, RC; Figueroa, AL; Gardecki, JA; Hoffmann, U; Subramanian, SS; Tawakol, A; Tearney, GJ; Truong, QA | 1 |
Kosugi, M; Magata, Y; Nakamura, S; Ogawa, M; Saito, Y | 1 |
Bologna, A; Casaretti, L; Conte, S; D'Amore, C; Dellegrottaglie, S; Formisano, R; Gargiulo, P; Leosco, D; Mosca, S; Musella, F; Parente, A; Perrone-Filardi, P; Pirozzi, E; Rengo, G | 1 |
Heinonen, SE; Knuuti, J; Laine, VJ; Laitinen, I; Nuutila, P; Roivainen, A; Saraste, A; Saukko, P; Savisto, N; Silvola, JM; Ylä-Herttuala, S | 1 |
Buettner, C; Fayad, ZA; Rudd, JH | 1 |
Hoit, BD; Longenecker, CT | 1 |
Barry, M; Crowe, M; Dolan, E; Foran, P; Grant, T; Hannon, N; Kavanagh, E; Kelly, PJ; Marnane, M; McDonnell, C; Merwick, A; Moroney, J; Murphy, S; Noone, I; O'Connell, M; O'Donohoe, M; O'Malley, K; O'Rourke, K; Sheehan, OC | 1 |
Camici, PG; Gaemperli, O; Libby, P; Rimoldi, OE | 1 |
Alavi, A; Gelfand, JM; Mehta, NN; Saboury, B; Torigian, DA | 1 |
Imaizumi, T; Tahara, A; Tahara, N; Takeuchi, M; Yamagishi, S | 1 |
Brown, K; Bucerius, J; Calcagno, C; Dickson, SD; Fayad, ZA; Fisher, EA; Fuster, V; Hayashi, K; Kotsuma, M; Lin, J; Moon, MJ; Moshier, E; Mounessa, JS; Nicolay, K; Ramachandran, S; Roytman, M; Rudd, JH; Tanimoto, T; Tsimikas, S; Vucic, E | 1 |
Alessio, A; Caldwell, J; Ferguson, M; Hatsukami, T; Kerwin, W; Kohler, T; Miyaoka, R; Yuan, C | 1 |
Beanlands, RS; Cocker, MS; Dekemp, RA; Hammond, RR; Lum, C; Mc Ardle, B; McDonald, MA; Ongaro, DC; Spence, JD; Tardif, JC | 1 |
32 review(s) available for fluorodeoxyglucose f18 and Atheroma
Article | Year |
---|---|
A new approach of statin therapy in carotid atherosclerosis: Targeting indices of plaque vulnerability on the top of lipid-lowering. A narrative review.
Topics: Biomarkers; Carotid Arteries; Carotid Artery Diseases; Carotid Stenosis; Cholesterol, LDL; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Magnetic Resonance Imaging; Plaque, Atherosclerotic | 2022 |
Imaging Carotid Plaque Inflammation Using Positron Emission Tomography: Emerging Role in Clinical Stroke Care, Research Applications, and Future Directions.
Topics: Animals; Coleoptera; Constriction, Pathologic; Fluorodeoxyglucose F18; Inflammation; Plaque, Amyloid; Plaque, Atherosclerotic; Positron-Emission Tomography; Stroke | 2023 |
Imaging findings and clinical relevance of
Topics: Atherosclerosis; Calcinosis; Clinical Relevance; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Receptors, CXCR4 | 2023 |
Atherosclerosis imaging using PET: Insights and applications.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Science to Practice: Does FDG Differentiate Morphologically Unstable from Stable Atherosclerotic Plaque?
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
PET Molecular Targets and Near-Infrared Fluorescence Imaging of Atherosclerosis.
Topics: Atherosclerosis; Coronary Vessels; Fluorescent Dyes; Fluorodeoxyglucose F18; Humans; Indocyanine Green; Injections, Intravenous; Plaque, Atherosclerotic; Positron-Emission Tomography; Spectroscopy, Near-Infrared; Tomography, Optical Coherence | 2018 |
New methods to image unstable atherosclerotic plaques.
Topics: Annexin A5; Apoptosis; Atherosclerosis; Coronary Artery Disease; Diagnostic Imaging; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Hypoxia; Inflammation; Ligands; Magnetic Resonance Imaging; Myocardial Infarction; Neovascularization, Physiologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Stroke; Tomography, X-Ray Computed | 2018 |
Topics: Aged; Asymptomatic Diseases; Carotid Arteries; Carotid Artery Diseases; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Male; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2018 |
Molecular imaging of coronary inflammation.
Topics: Clinical Decision-Making; Coronary Artery Disease; Coronary Vessels; Fluorodeoxyglucose F18; Humans; Inflammation; Molecular Imaging; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors | 2019 |
Evolving Role of PET in Detecting and Characterizing Atherosclerosis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Contrast Media; Coronary Artery Disease; Disease Models, Animal; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits; Risk Factors; Sodium Fluoride; Swine; Young Adult | 2019 |
PET/MR Imaging in Cardiovascular Imaging.
Topics: Cardiomyopathies; Cardiovascular Diseases; Contrast Media; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Multimodal Imaging; Myocardial Perfusion Imaging; Myocarditis; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2019 |
Nuclear Imaging: Focus on Vascular Probes
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Molecular Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
Topics: Calcinosis; Coronary Angiography; Coronary Artery Disease; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Rupture, Spontaneous; Sodium Fluoride; Tomography, X-Ray Computed | 2013 |
Hypoxia in atherosclerosis and inflammation.
Topics: Animals; Atherosclerosis; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Inflammation; Lipid Metabolism; Macrophages; Magnetic Resonance Angiography; Plaque, Atherosclerotic; Radiography; Signal Transduction | 2013 |
PET imaging of inflammation in atherosclerosis.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Molecular imaging of the atherosclerotic plaque using positron emission tomography.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Tomography, X-Ray Computed | 2014 |
Noninvasive imaging of arterial inflammation using FDG-PET/CT.
Topics: Anti-Inflammatory Agents; Arteritis; Blood Component Removal; Cholesterol, LDL; Clinical Trials as Topic; Drugs, Investigational; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Plaque, Atherosclerotic; Positron-Emission Tomography; Risk Factors | 2014 |
PET imaging of atherosclerosis.
Topics: Atherosclerosis; Calcinosis; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoxia; Inflammation; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment; Stroke; Tomography, X-Ray Computed | 2015 |
Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
Topics: Algorithms; Atherosclerosis; Carotid Arteries; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Likelihood Functions; Magnetic Resonance Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2015 |
Advances in MRI for the evaluation of carotid atherosclerosis.
Topics: Carotid Artery Diseases; Carotid Artery, Internal; Fluorodeoxyglucose F18; Hemorrhage; Humans; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Plaque, Atherosclerotic; Radiopharmaceuticals | 2015 |
Exploring the nature of atheroma and cardiovascular inflammation in vivo using positron emission tomography (PET).
Topics: Aortic Aneurysm; Atherosclerosis; Coronary Vessels; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Vascular Calcification; Vasculitis | 2015 |
Review of cardiovascular imaging in the journal of nuclear cardiology in 2015. Part 1 of 2: Plaque imaging, positron emission tomography, computed tomography, and magnetic resonance.
Topics: Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Angiography; Periodicals as Topic; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Preclinical models of atherosclerosis. The future of Hybrid PET/MR technology for the early detection of vulnerable plaque.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Metal Nanoparticles; Mice; Mice, Knockout; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Radiography; Radiopharmaceuticals; Receptors, LDL | 2016 |
Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
Topics: Animals; Arteries; Atherosclerosis; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Severity of Illness Index; Sodium Fluoride | 2016 |
Imaging unstable plaque.
Topics: Animals; Arteries; Calcinosis; Cardiovascular Diseases; Coronary Angiography; Fluorodeoxyglucose F18; Humans; Hypoxia; Inflammation; Magnetic Resonance Imaging; Mice; Molecular Probes; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Risk; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2016 |
FDG-PET imaging of atherosclerosis: Do we know what we see?
Topics: Cardiology; Coronary Artery Disease; Coronary Vessels; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kinetics; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Risk | 2010 |
Imaging of atherosclerosis.
Topics: Animals; Atherosclerosis; Carotid Artery Diseases; Carotid Stenosis; Constriction, Pathologic; Endothelium, Vascular; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mice; Plaque, Atherosclerotic; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2011 |
PET imaging of aortic atherosclerosis: Is combined imaging of plaque anatomy and function an amaranthine quest or conceivable reality?
Topics: Aortic Diseases; Atherosclerosis; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2011 |
[From myocardium to the atherosclerotic plaque: new perspectives in cardiologic imaging].
Topics: Cardiology; Contrast Media; Dextrans; Echocardiography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Molecular Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Imaging atherosclerosis in HIV: carotid intima-media thickness and beyond.
Topics: Atherosclerosis; Brachial Artery; Carotid Intima-Media Thickness; Coronary Vessels; Endothelium, Vascular; Fluorodeoxyglucose F18; HIV Infections; Humans; Inflammation; Magnetic Resonance Angiography; Molecular Imaging; Plaque, Atherosclerotic; Radiography; Tomography, Emission-Computed; Tomography, Optical Coherence | 2012 |
Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque.
Topics: Animals; Atherosclerosis; Contrast Media; Diagnostic Imaging; Fluorodeoxyglucose F18; Hemorrhage; Humans; Isoquinolines; Mice; Microbubbles; Monocytes; Plaque, Atherosclerotic; Rabbits; Radiopharmaceuticals; Receptors, GABA; Tunica Intima; Vascular Calcification | 2012 |
Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
10 trial(s) available for fluorodeoxyglucose f18 and Atheroma
Article | Year |
---|---|
Bone marrow activation in response to metabolic syndrome and early atherosclerosis.
Topics: Atherosclerosis; Biomarkers; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Thoracic; Atherosclerosis; Atorvastatin; Carotid Arteries; Double-Blind Method; Feasibility Studies; Female; Fluorodeoxyglucose F18; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Pyrroles; Treatment Outcome | 2013 |
Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.
Topics: Amides; Aorta; Aortic Diseases; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Double-Blind Method; Esters; Fluorodeoxyglucose F18; Humans; Hypolipidemic Agents; Inflammation Mediators; Longitudinal Studies; Multimodal Imaging; Peroxidase; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sulfhydryl Compounds; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Plaque, Atherosclerotic; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Rupture, Spontaneous; Scotland; Sodium Fluoride; Tomography, X-Ray Computed | 2014 |
Varying correlation between 18F-fluorodeoxyglucose positron emission tomography and dynamic contrast-enhanced MRI in carotid atherosclerosis: implications for plaque inflammation.
Topics: Aged; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2014 |
A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: implications for vulnerable coronary plaque imaging.
Topics: Adult; Coronary Vessels; Diet; Fatty Acids, Nonesterified; Female; Fluorodeoxyglucose F18; Healthy Volunteers; Humans; Inflammation; Lipids; Male; Olive Oil; Plant Oils; Plaque, Atherosclerotic; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Time Factors; Tomography, X-Ray Computed; Verapamil | 2014 |
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
Topics: Aged; Anti-Inflammatory Agents; Aortic Diseases; Atherosclerosis; Atorvastatin; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Male; Middle Aged; Multimodal Imaging; p38 Mitogen-Activated Protein Kinases; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Protein Kinase Inhibitors; Pyrroles; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazines; United States | 2015 |
Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation.
Topics: Adenosine; Aged; Anti-Inflammatory Agents; Carotid Arteries; Carotid Stenosis; Clopidogrel; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Radiopharmaceuticals; Republic of Korea; Severity of Illness Index; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Adolescent; Adult; Aged; Amides; Anticholesteremic Agents; Coronary Disease; Diagnosis, Differential; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Esters; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sulfhydryl Compounds; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2011 |
Investigating vulnerable atheroma using combined (18)F-FDG PET/CT angiography of carotid plaque with immunohistochemical validation.
Topics: Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biological Assay; Carotid Arteries; Carotid Stenosis; Endarterectomy, Carotid; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Macrophages; Male; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Regression Analysis; Reproducibility of Results; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A | 2011 |
110 other study(ies) available for fluorodeoxyglucose f18 and Atheroma
Article | Year |
---|---|
Abdominal Visceral Adiposity Is Associated with Coronary Artery Plaque Lipid-Rich Necrotic Core Partly Mediated by Bone Marrow Uptake of
Topics: Adiposity; Bone Marrow; Coronary Vessels; Fluorodeoxyglucose F18; Humans; Lipids; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Psoriasis | 2022 |
Simultaneous [18F]fluoride and gadobutrol enhanced coronary positron emission tomography/magnetic resonance imaging for in vivo plaque characterization.
Topics: Aged; Atherosclerosis; Coronary Artery Disease; Fluorides; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Organometallic Compounds; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Plasma sICAM-1 as a Biomarker of Carotid Plaque Inflammation in Patients with a Recent Ischemic Stroke.
Topics: Biomarkers; Carotid Stenosis; Fluorodeoxyglucose F18; Humans; Inflammation; Intercellular Adhesion Molecule-1; Ischemic Stroke; Plaque, Atherosclerotic; Positron-Emission Tomography; Prospective Studies; Stroke | 2022 |
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride | 2022 |
Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not.
Topics: Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride | 2022 |
[
Topics: Atherosclerosis; Cardiovascular Diseases; Fluorodeoxyglucose F18; Gallium Radioisotopes; Heart Disease Risk Factors; Humans; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Vena Cava, Superior | 2022 |
Semi-Quantitative [
Topics: Aortitis; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2022 |
Non-calcified active atherosclerosis plaque detection with 18F-NaF and 18F-FDG PET/CT dynamic imaging.
Topics: Aged; Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by
Topics: Adult; Biomarkers; Fluorodeoxyglucose F18; Humans; Inflammation; Ischemic Stroke; Lipoproteins, LDL; Plaque, Atherosclerotic; Prospective Studies; Stroke | 2023 |
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors.
Topics: Cardiovascular Diseases; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Heart Disease Risk Factors; Humans; Molecular Imaging; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Quinolines; Risk Factors; Vascular Calcification | 2023 |
Symptomatic Carotid Atheroma Inflammation Lumen-stenosis score compared with Oxford and Essen risk scores to predict recurrent stroke in symptomatic carotid stenosis.
Topics: Brain Ischemia; Carotid Stenosis; Cerebral Infarction; Constriction, Pathologic; Fluorodeoxyglucose F18; Humans; Inflammation; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Prospective Studies; Risk Factors; Stroke | 2023 |
Serum active 1,25(OH)
Topics: Adiposity; Aged; Cardiovascular Diseases; Coronary Angiography; Coronary Vessels; Female; Fluorodeoxyglucose F18; Humans; Immunoassay; Intra-Abdominal Fat; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Prospective Studies; Psoriasis; Risk; Vitamin D | 2019 |
Fluorodeoxyglucose Uptake in Atheroma: Not So Simple.
Topics: Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography | 2019 |
Biomechanical characteristics of isolated carotid atherosclerotic plaques assessed by ultrasonography.
Topics: Aged; Atherosclerosis; Carotid Arteries; Carotid Intima-Media Thickness; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Linear Models; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Pulse Wave Analysis; ROC Curve; Sensitivity and Specificity | 2019 |
Fluorine-18 fluorodeoxyglucose positron emission tomography-based textural features for prediction of event prone carotid atherosclerotic plaques.
Topics: Aged; Carotid Stenosis; Endarterectomy, Carotid; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2021 |
Hiding beyond plain sight: Textural analysis of positron emission tomography to identify high-risk plaques in carotid atherosclerosis.
Topics: Carotid Artery Diseases; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Topics: Aged; Blood Flow Velocity; Carotid Artery Diseases; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Advanced ultrasound methods in assessment of carotid plaque instability: a prospective multimodal study.
Topics: Aged; Carotid Arteries; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Prospective Studies; Ultrasonography | 2020 |
Characterization of glucose uptake metabolism in visceral fat by 18 F-FDG PET/CT reflects inflammatory status in metabolic syndrome.
Topics: Aged; Bone Marrow; Female; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Intra-Abdominal Fat; Male; Metabolic Syndrome; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Spleen | 2020 |
Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fluorodeoxyglucose F18; Inflammation; Linagliptin; Mice; Mice, Knockout; Plaque, Atherosclerotic; Positron-Emission Tomography | 2020 |
No pleotropic effects of linagliptin on atherosclerotic plaques: Case closed.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fluorodeoxyglucose F18; Inflammation; Linagliptin; Mice; Plaque, Atherosclerotic | 2020 |
Stress-associated neurobiological activity is linked with acute plaque instability via enhanced macrophage activity: a prospective serial 18F-FDG-PET/CT imaging assessment.
Topics: Female; Fluorodeoxyglucose F18; Humans; Macrophages; Male; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2021 |
Evaluation of non-stenotic carotid atherosclerotic plaques with combined FDG-PET imaging and CT angiography in patients with ischemic stroke of unknown origin.
Topics: Carotid Arteries; Computed Tomography Angiography; Fluorodeoxyglucose F18; Humans; Ischemic Stroke; Plaque, Atherosclerotic; Positron-Emission Tomography; Retrospective Studies; Stroke | 2022 |
Subclinical Atherosclerosis and Brain Metabolism in Middle-Aged Individuals: The PESA Study.
Topics: Adult; Asymptomatic Diseases; Atherosclerosis; Brain; Carotid Arteries; Cohort Studies; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Ultrasonography | 2021 |
Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease.
Topics: Aged; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Atorvastatin; Cardiovascular Diseases; Carotid Arteries; Cholesterol, LDL; Female; Fluorodeoxyglucose F18; Heart Disease Risk Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Renal Insufficiency, Chronic; Risk Factors | 2021 |
Imaging Immunometabolism in Atherosclerosis.
Topics: Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic | 2021 |
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Tomography, X-Ray Computed | 2021 |
Atherosclerotic plaque metabolism in high cardiovascular risk subjects - A subclinical atherosclerosis imaging study with
Topics: Adult; Calcinosis; Cardiovascular Diseases; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Molecular Imaging; Plaque, Atherosclerotic; Portugal; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prevalence; Prospective Studies; Radiopharmaceuticals; Risk Factors; Survival Rate | 2017 |
Lesion contrast recovery for partial-volume averaging: Quantitative correction or qualitative enhancement?
Topics: Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography | 2018 |
Imaging Vulnerable Plaque: A Medical Necessity or a Scientific Curiosity?
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Organometallic Compounds; Plaque, Atherosclerotic; Positron-Emission Tomography | 2017 |
Vascular Imaging With
Topics: Aged; Carotid Arteries; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Stroke | 2017 |
Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
Topics: Animal Feed; Animals; Aortic Diseases; Apolipoprotein B-100; Atherosclerosis; Atorvastatin; Diet, Fat-Restricted; Diet, High-Fat; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipids; Male; Mice, Knockout; Phenotype; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, LDL; Time Factors | 2017 |
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography an
Topics: Acute Coronary Syndrome; Adult; Aorta, Thoracic; Coronary Angiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Optical Coherence | 2017 |
Characterization of Macrophage Polarization States Using Combined Measurement of 2-Deoxyglucose and Glutamine Accumulation: Implications for Imaging of Atherosclerosis.
Topics: Animals; Aorta; Atherosclerosis; Autoradiography; Deoxyglucose; Fluorodeoxyglucose F18; Glutamine; Macrophages; Mice; Plaque, Atherosclerotic; Positron-Emission Tomography | 2017 |
Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET/CT.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Observer Variation; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography | 2017 |
Association of Tumor Necrosis Factor Inhibitor Treatment With Reduced Indices of Subclinical Atherosclerosis in Patients With Psoriatic Disease.
Topics: Adult; Aged; Antirheumatic Agents; Atherosclerosis; Canada; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Prospective Studies; Psoriasis; Risk Factors; Tumor Necrosis Factor-alpha | 2018 |
CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT in patients at risk for cardiovascular disease.
Topics: Aged; Arteries; Arteritis; Atherosclerosis; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monocytes; Phenotype; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, CCR2 | 2018 |
Imaging inflammation in atherosclerotic plaques: Just make it easy!
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Inflammation; Lymphocyte Function-Associated Antigen-1; Plaque, Atherosclerotic; Positron-Emission Tomography | 2019 |
Effect of moderate-intensity statin therapy on plaque inflammation in patients with acute coronary syndrome: A prospective interventional study evaluated by 18F-FDG PET/CT of the carotid artery.
Topics: Acute Coronary Syndrome; Carotid Arteries; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Prospective Studies | 2020 |
Inflammation Coupling Between Unstable Carotid Plaque and Spleen-A
Topics: Aged; Carotid Artery, Internal; Carotid Stenosis; Case-Control Studies; Endarterectomy, Carotid; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Magnetic Resonance Imaging; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rupture, Spontaneous; Spleen | 2018 |
Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond
Topics: Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
Comparison of [
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Sodium Fluoride; Vascular Calcification | 2019 |
Assessment of artery calcification in atherosclerosis with dynamic 18F-FDG-PET/CT imaging in elderly subjects.
Topics: Age Factors; Aged; Aged, 80 and over; Coronary Artery Disease; Coronary Vessels; Female; Fluorodeoxyglucose F18; Humans; Male; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Severity of Illness Index; Vascular Calcification | 2019 |
Vascular Positron Emission Tomography and Restenosis in Symptomatic Peripheral Arterial Disease: A Prospective Clinical Study.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peripheral Arterial Disease; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recurrence; Risk Factors; Sodium Fluoride; Time Factors; Treatment Outcome | 2020 |
New insight of molecular imaging into the atheroma biology: (18)F-fluoride PET/CT and 18F-FDG PET/CT of 3 carotid plaques in a symptomatic neurologic patient.
Topics: Aged; Carotid Stenosis; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Multimodal Imaging; Plaque, Atherosclerotic; Radiography; Radionuclide Imaging; Stroke | 2013 |
Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
Topics: Animals; Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Atorvastatin; Contrast Media; Dextrans; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Magnetic Resonance Imaging; Magnetite Nanoparticles; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Pyrroles; Rabbits; Radiography; Radiopharmaceuticals; Time Factors | 2013 |
Detection of vulnerable atherosclerotic plaque and prediction of thrombosis events in a rabbit model using 18F-FDG -PET/CT.
Topics: Animals; Aorta; Aortography; Disease Models, Animal; Fluorodeoxyglucose F18; Male; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; ROC Curve; Thrombosis; Tomography, X-Ray Computed | 2013 |
Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
Topics: Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Carotid Arteries; Carotid Artery Diseases; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Rupture, Spontaneous; Stroke | 2013 |
Identification of inflamed aortic plaque in conventional fluorodeoxyglucose-positron emission tomography myocardial viability studies.
Topics: Aged; Aorta; Coronary Artery Disease; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Retrospective Studies; Tissue Survival; Tomography, X-Ray Computed; Ventricular Dysfunction, Left | 2013 |
Delayed time-point 18F-FDG PET CT imaging enhances assessment of atherosclerotic plaque inflammation.
Topics: Biological Transport; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed | 2013 |
Arterial (18)F-fluorodeoxyglucose uptake reflects balloon catheter-induced thrombus formation and tissue factor expression via nuclear factor-κB in rabbit atherosclerotic lesions.
Topics: Animals; Atherosclerosis; Catheters; Fluorodeoxyglucose F18; Gene Expression Regulation; Magnetic Resonance Angiography; Male; NF-kappa B; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Radiography; Radiopharmaceuticals; Thromboplastin; Thrombosis | 2013 |
Neovascularization in the carotid atherosclerotic plaque is not associated with inflammatory cell aggregation.
Topics: Aged; Aged, 80 and over; Carotid Artery Diseases; Cell Aggregation; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
[Noninvasive imaging of vulnerable plaques and thromboses with PET/CT complex imaging technique].
Topics: Angiography; Animals; Atherosclerosis; Fluorodeoxyglucose F18; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Thrombosis | 2013 |
Combined 18F-FDG PET-CT and DCE-MRI to assess inflammation and microvascularization in atherosclerotic plaques.
Topics: Aged; Brain Ischemia; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Plaque, Atherosclerotic; Radionuclide Imaging; Radiopharmaceuticals; Stroke | 2013 |
A new frontier in atherosclerotic coronary imaging.
Topics: Coronary Angiography; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
18F-FDG PET and intravascular ultrasonography (IVUS) images compared with histology of atherosclerotic plaques: 18F-FDG accumulates in foamy macrophages.
Topics: Animals; Aorta; Fluorodeoxyglucose F18; Foam Cells; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Ultrasonography, Interventional | 2014 |
Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
Topics: Aged; Atherosclerosis; Biomarkers; Carotid Artery, Internal; Carotid Stenosis; Endarterectomy, Carotid; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed | 2014 |
Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study.
Topics: Amides; Anticholesteremic Agents; Coronary Artery Disease; Esters; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sulfhydryl Compounds; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Comparison of fluorodeoxyglucose uptake in symptomatic carotid artery and stable femoral artery plaques.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Cerebrovascular Disorders; Endarterectomy; Endarterectomy, Carotid; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ischemia; Leg; Macrophages; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Thromboembolism | 2014 |
Imaging atherosclerotic plaque inflammation via folate receptor targeting using a novel 18F-folate radiotracer.
Topics: Aged; Aged, 80 and over; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Arteries; Female; Fluorodeoxyglucose F18; Folate Receptor 2; Humans; Immunohistochemistry; Inflammation; Male; Mice; Middle Aged; Models, Biological; Molecular Imaging; Plaque, Atherosclerotic | 2014 |
Serial F-18-FDG PET/CT distinguishes inflamed from stable plaque phenotypes in shear-stress induced murine atherosclerosis.
Topics: Animals; Apolipoproteins E; Carotid Artery Diseases; Cholesterol, Dietary; Diagnosis, Differential; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Inflammation; Phenotype; Plaque, Atherosclerotic; Positron-Emission Tomography | 2014 |
Serum lipids associated with inflammation-related PET-FDG uptake in symptomatic carotid plaque.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Cholesterol; Cohort Studies; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Triglycerides | 2014 |
In vivo mapping of vascular inflammation using the translocator protein tracer 18F-FEDAA1106.
Topics: Acetamides; Animals; Carotid Arteries; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred C57BL; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Evaluation of inflamed coronary atherosclerotic plaques by PET: more evidences for a promising area of cardiovascular imaging.
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Inflammation; Plaque, Atherosclerotic; Positron-Emission Tomography | 2014 |
Association between nonalcoholic fatty liver disease and carotid artery inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carotid Artery Diseases; Carotid Intima-Media Thickness; Chi-Square Distribution; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Odds Ratio; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Factors; Severity of Illness Index; Tomography, X-Ray Computed | 2015 |
18F-FDG uptake and calcifications on positron emission tomography/computed tomography in octogenarians with severe aortic stenosis.
Topics: Aged, 80 and over; Aortic Valve Stenosis; Calcinosis; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Incidence; Inflammation; Male; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed | 2015 |
[¹⁸F-NaF PET-CT: a new method for imaging of ruptured and rupture-endangered atherosclerotic plaques].
Topics: Coronary Angiography; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Detection of a right carotid focus of 18F-FDG predicted an ischemic stroke.
Topics: Brain Ischemia; Carotid Arteries; Cerebral Arteries; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Stroke; Tomography, X-Ray Computed | 2015 |
Increased microvascularization and vessel permeability associate with active inflammation in human atheromata.
Topics: Aged; Biomarkers; Capillary Permeability; Carotid Arteries; Carotid Stenosis; Contrast Media; Female; Fluorodeoxyglucose F18; Histocompatibility Antigens Class II; Humans; Inflammation; Inflammation Mediators; Linear Models; Macrophages; Magnetic Resonance Imaging; Male; Microvessels; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed | 2014 |
Fiber-optic system for dual-modality imaging of glucose probes 18F-FDG and 6-NBDG in atherosclerotic plaques.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Carotid Artery Diseases; Diagnostic Imaging; Fiber Optic Technology; Fluorodeoxyglucose F18; Glucosamine; Male; Mice; Plaque, Atherosclerotic; Radionuclide Imaging; Radiopharmaceuticals | 2014 |
Plaque Thrombosis is Reduced by Attenuating Plaque Inflammation with Pioglitazone and is Evaluated by Fluorodeoxyglucose Positron Emission Tomography.
Topics: Animals; Biomarkers; Blood Glucose; C-Reactive Protein; Fluorodeoxyglucose F18; Hypoglycemic Agents; Inflammation; Lipids; Male; Matrix Metalloproteinase 9; Pioglitazone; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Thiazolidinediones; Thrombosis; Tomography, X-Ray Computed | 2015 |
Plaque Inflammation Imaging in Severe Carotid Stenosis and Recurrent Cerebral Ischemia.
Topics: Brain Ischemia; Carotid Stenosis; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Recurrence | 2015 |
Scintillating balloon-enabled fiber-optic system for radionuclide imaging of atherosclerotic plaques.
Topics: Animals; Fluorodeoxyglucose F18; Male; Mice; Optical Fibers; Plaque, Atherosclerotic; Radionuclide Imaging | 2015 |
Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
Topics: Aged; Aged, 80 and over; Aorta; Aortic Diseases; Aortography; Arteries; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Iliac Artery; Linear Models; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Vascular Calcification | 2016 |
In Vivo Imaging of Hypoxia in Atherosclerotic Plaques in Humans.
Topics: Aged; Aorta; Aortic Diseases; Aortography; Carotid Arteries; Carotid Stenosis; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Male; Middle Aged; Multimodal Imaging; Oxygen; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed; Triazoles | 2015 |
New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results.
Topics: Aged; Aged, 80 and over; Asymptomatic Diseases; Carotid Arteries; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Humans; Ischemic Attack, Transient; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sodium Fluoride; Stroke; Vascular Calcification | 2016 |
High resolution FDG-microPET of carotid atherosclerosis: plaque components underlying enhanced FDG uptake.
Topics: Aged; Aged, 80 and over; Carotid Arteries; Carotid Artery Diseases; Endarterectomy, Carotid; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Vascular Calcification | 2016 |
Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction.
Topics: Aged; Aortitis; Atherosclerosis; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Myocardial Infarction; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recurrence; Registries; Risk Factors; Scotland; Time Factors; Tomography, X-Ray Computed; Troponin | 2015 |
Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Bone Marrow; Carotid Artery Diseases; Cell Proliferation; Cholesterol, Dietary; Dideoxynucleosides; Diet, High-Fat; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cells; Humans; Macrophages; Male; Mice, Inbred C57BL; Mice, Knockout; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Retrospective Studies; Spleen; Time Factors; Tomography, X-Ray Computed | 2015 |
High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Stroke | 2016 |
Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.
Topics: Analysis of Variance; Animals; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Endothelial Cells; Female; Fluorodeoxyglucose F18; In Vitro Techniques; Inflammation; Mice; Mice, Inbred C57BL; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Random Allocation; Sensitivity and Specificity; Single-Domain Antibodies; Vascular Cell Adhesion Molecule-1 | 2016 |
Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system.
Topics: Aged; Aged, 80 and over; Carotid Artery Diseases; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Reproducibility of Results | 2016 |
The high matrix acquisition technique for imaging of atherosclerotic plaque inflammation in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography with time-of-flight: Phantom study.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Phantoms, Imaging; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography | 2017 |
Patients with an Inflamed Atherosclerotic Plaque have Increased Levels of Circulating Inflammatory Markers.
Topics: Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; E-Selectin; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; P-Selectin; Plaque, Atherosclerotic; Positron-Emission Tomography; Tissue Distribution | 2017 |
In Vivo Molecular Imaging of Ruptured Coronary Atherosclerotic Plaque Using IVUS, OCT, and FDG-PET/CT.
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Ultrasonography, Interventional | 2016 |
Observations With Simultaneous 18F-FDG PET and MR Imaging in Peripheral Artery Disease.
Topics: Femoral Artery; Fibrosis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Peripheral Arterial Disease; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Severity of Illness Index | 2017 |
Inflamed human carotid plaques evaluated by PET/CT exhibit increased temperature: insights from an in vivo study.
Topics: Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Body Temperature; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Microwaves; Plaque, Atherosclerotic; Platelet Endothelial Cell Adhesion Molecule-1; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vascular Calcification | 2017 |
PET/CTA detection of muscle inflammation related to cholesterol crystal emboli without arterial obstruction.
Topics: Animals; Arteries; Biomarkers; Cholesterol; Computed Tomography Angiography; Crystallization; Fluorodeoxyglucose F18; Inflammation; Injections, Intra-Arterial; Microspheres; Muscle, Skeletal; Myositis; Necrosis; Plaque, Atherosclerotic; Polystyrenes; Positron-Emission Tomography; Rabbits; Thrombosis | 2018 |
Molecular Imaging of Atheroma: Deciphering How and When to Use
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Tomography, X-Ray Computed | 2017 |
18F-FDG uptake and calcifications in the thoracic aorta on positron emission tomography/computed tomography examinations: frequency and stability on serial scans.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Thoracic; Drug Stability; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Observer Variation; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Tomography, Emission-Computed | 2011 |
Localization of deoxyglucose and annexin A5 in experimental atheroma correlates with macrophage infiltration but not lipid deposition in the lesion.
Topics: Animals; Annexin A5; Aorta; Apolipoproteins E; Autoradiography; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lipid Metabolism; Macrophages; Male; Mice; Mice, Inbred C57BL; Plaque, Atherosclerotic; Radionuclide Imaging; Regression Analysis; Technetium | 2011 |
Lymph nodes as a potential pitfall in carotid plaque imaging with FDG-PET/CT.
Topics: Aged; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Plaque, Atherosclerotic; Positron-Emission Tomography | 2011 |
Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation.
Topics: Age Distribution; Aged; Carotid Stenosis; Cohort Studies; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Periodontal Diseases; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Risk Assessment; Severity of Illness Index; Sex Distribution; Survival Rate | 2011 |
Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Animals; Aorta; Atherosclerosis; Fluorodeoxyglucose F18; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits | 2011 |
Quantification of [18F]-FDG uptake in atherosclerotic plaque: impact of renal function.
Topics: Adult; Aged; Atherosclerosis; Female; Fluorodeoxyglucose F18; Glomerular Filtration Rate; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Risk Factors; Tomography, X-Ray Computed | 2011 |
Imaging of vulnerable plaques: will it affect patient management and influence outcomes?
Topics: Calcinosis; Coronary Angiography; Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Arteries; Biological Transport; Calcinosis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Minerals; Plaque, Atherosclerotic; Positron-Emission Tomography; Radioactive Tracers; Retrospective Studies; Risk Factors; Sodium Fluoride; Tomography, X-Ray Computed; Young Adult | 2011 |
Microvessel density but not neoangiogenesis is associated with 18F-FDG uptake in human atherosclerotic carotid plaques.
Topics: Aged; Aged, 80 and over; Antigens, CD34; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Integrins; Linear Models; Male; Microvessels; Middle Aged; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Vascular Endothelial Growth Factor A | 2012 |
Reduced myocardial 18F-FDG uptake after calcium channel blocker administration. Initial observation for a potential new method to improve plaque detection.
Topics: Animals; Biological Transport; Calcium Channel Blockers; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred C57BL; Myocardium; Plaque, Atherosclerotic; Positron-Emission Tomography; Verapamil | 2011 |
Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography.
Topics: Animals; Anticholesteremic Agents; Aorta; Azetidines; C-Reactive Protein; Cholesterol; Crystallization; Ezetimibe; Fluorodeoxyglucose F18; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Thrombosis | 2011 |
Myo-Myo: Yes, papa. Eating sugar? No, papa! Modulating the myocardial menu for imaging coronary inflammation...
Topics: Animals; Calcium Channel Blockers; Fluorodeoxyglucose F18; Male; Myocardium; Plaque, Atherosclerotic; Positron-Emission Tomography | 2011 |
Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology.
Topics: Aged; Atherosclerosis; Carotid Stenosis; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Iopamidol; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2012 |
What can be seen by 18F-FDG PET in atherosclerosis imaging? The effect of foam cell formation on 18F-FDG uptake to macrophages in vitro.
Topics: Animals; Aorta; Biological Transport; Female; Fluorodeoxyglucose F18; Foam Cells; Glucose Transporter Type 1; Glucose-6-Phosphatase; Hexokinase; Mice; Myocytes, Smooth Muscle; Plaque, Atherosclerotic; Positron-Emission Tomography | 2012 |
Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
Topics: Age Factors; Aging; Animals; Aorta; Aortography; Apolipoprotein B-100; Atherosclerosis; Autoradiography; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Fluorodeoxyglucose F18; Immunohistochemistry; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, IGF Type 2; Receptors, LDL; Risk Factors; Tomography, X-Ray Computed | 2011 |
Determinants of FDG uptake in atherosclerosis.
Topics: Aging; Animals; Atherosclerosis; Diabetes Mellitus, Type 2; Diet, High-Fat; Fluorodeoxyglucose F18; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence.
Topics: Aged; Carotid Stenosis; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Inflammation; Male; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity; Stroke; Tomography, X-Ray Computed | 2012 |
Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
Topics: Blood Glucose; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Serum levels of pigment epithelium-derived factor, a novel marker of insulin resistance, are independently associated with fasting apolipoprotein B48 levels in humans.
Topics: Adult; Aged; Aged, 80 and over; Apolipoprotein B-48; Biomarkers; Carotid Artery Diseases; Carotid Intima-Media Thickness; Eye Proteins; Fasting; Female; Fluorodeoxyglucose F18; Glycation End Products, Advanced; Humans; Insulin Resistance; Male; Middle Aged; Nerve Growth Factors; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Serpins | 2012 |
Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin.
Topics: Animals; Apolipoproteins B; Atorvastatin; Disease Progression; Fluorodeoxyglucose F18; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Liver X Receptors; Macrophages; Multimodal Imaging; Orphan Nuclear Receptors; Plaque, Atherosclerotic; Positron-Emission Tomography; Pyrroles; Rabbits; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
High-resolution [18]fluorodeoxyglucose-positron emission tomography and coregistered magnetic resonance imaging of atherosclerotic plaque from a patient undergoing carotid endarterectomy.
Topics: Aged, 80 and over; Asymptomatic Diseases; Carotid Arteries; Carotid Stenosis; Endarterectomy, Carotid; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index | 2012 |